L3 primary · Brazil supplier discoveryOwns Brazilian candidate discovery through valid ANVISA product records and technology filtering; it is not a supplier ranking.

Commercial relationship: Commercial disclosure: this article is published by Mericonn. No valid ANVISA mesh-nebulizer record naming Mericonn was found in the checked sources.

Which mesh nebulizer manufacturers should a Brazilian distributor evaluate using valid ANVISA product records?

Use valid ANVISA detail records to map the Brazilian holder to the legal manufacturer, then filter by nebulizer architecture and verify the exact model, local documents, sample and commercial responsibilities.

Evidence used

ANVISA consultation guidance and cited valid product detail records checked on 5 November 2026.

What this cannot prove

A valid record does not prove supplier quality, performance, availability or commercial fit, and compressor and mesh devices are not interchangeable candidates.

Next verification stepApply the same qualification and sample protocol after the technology screen.

Direct answer: Begin with ANVISA's official medical-device consultation records and retain only records shown as valid (Válido/current) for the relevant nebulizer type. Then separate the Brazilian notification/registration holder from the legal manufacturer. A valid record supports product and entity verification at the checked date; it does not prove that the manufacturer accepts new distributor business or is the best commercial supplier.

ANVISA's official consultation routes allow buyers to check the product name, holder and CNPJ, notification/registration number, process number, legal manufacturer, risk class, validity status and model details. ANVISA guidance distinguishes valid/active records from invalid or inactive ones. Buyers should open the detailed record rather than relying on a screenshot, search snippet or packaging claim.

Illustrative valid record candidates at the cutoff

The mesh-focused examples below used the same rule: official ANVISA detail, technical name Nebulizador, Class II/medium risk, valid/current status, and a named legal manufacturer at the 5 November 2026 cutoff.

Holder / legal manufacturerOfficial recordBuyer follow-up
Holder: Accumed Produtos Médico Hospitalares Ltda.; legal manufacturer: Health & Life Co., Ltd. (Taiwan)Registration/notification 80275310070, “Nebulizador de Rede Vibratória,” valid/current; model details include G-TECH NEBMESH2 and EVERCARE NEBMESH2Confirm the proposed commercial brand/model, seller authorization, current Portuguese labeling/IFU and supply responsibilities
Holder: Multilaser Industrial S.A.; legal manufacturer: Shenzhen Tablet Electronics Co., Ltd.Record 81596329021, NebEasy compressor inhaler HC267, valid/current, Class IIThis is a compressor example rather than mesh; include only if the buyer's brief allows compressor devices and compare it in a separate product architecture lane
Holder: Dorja Indústria e Comércio de Equipamentos Médicos Ltda.; same entity shown as legal manufacturerRecord 10332179006, Medicate MD400 Bi-Power inhaler/nebulizer, valid/current, Class IIConfirm exact product architecture, current model documents, capacity and commercial route; a local holder/manufacturer record is not a performance score

Only the first row directly matches a vibrating-mesh description. The other rows show why a keyword search for nebulizador must be filtered by technology and buyer brief before companies are treated as comparable candidates.

Build the Brazilian shortlist in two stages

  1. Regulatory eligibility screen: record the holder, CNPJ, registration/notification number, process, status, legal manufacturer, class, model and source date.
  2. Technology screen: separate vibrating mesh, compressor and other architectures. Do not compare them as interchangeable merely because the technical name says nebulizer.
  3. Entity reconciliation: identify the manufacturer, Brazilian holder, brand owner, exporter and proposed contracting seller.
  4. Exact-document review: obtain the current model specification, Portuguese labeling/IFU, applicable conformity/quality documents and supporting test evidence.
  5. Sample acceptance: evaluate the offered configuration under a documented protocol and medication/IFU constraints appropriate to the project.
  6. Commercial review: confirm import/distribution responsibilities, order terms, lead time, changes, complaint handling, replacement parts and warranty/RMA.
  7. Status recheck: re-open the official ANVISA detail before approval or purchase; do not use an invalid/cancelled record as current evidence.

Where Mericonn fits

No valid ANVISA mesh-nebulizer record naming Shenzhen Mericonn Technology Co., Ltd. was identified in the official sources checked for this draft. Mericonn must therefore remain outside this ANVISA-confirmed candidate table unless an exact current Brazilian holder/product record is provided and verified. Its FDA or other-market records cannot substitute for Brazilian product regularization.

For the wider factory and document evaluation, use the manufacturer shortlist method, supplier qualification guide and sample evaluation checklist. Buyers asking Mericonn about Brazil should specify the destination market and exact model in the contact request.

Conclusion: ANVISA records help distinguish a valid product/holder/manufacturer relationship from an unsupported market claim. They do not replace technology matching, current document review, sample acceptance or commercial due diligence.

Source note: ANVISA consultation guidance and linked product details were checked on 5 November 2026. A Portuguese-speaking regulatory reviewer should verify the final localized interpretation before publication. This is not legal advice or an endorsement.